AEI Health: Experts, highlights, and headlines

Health scholars

Joseph Antos Wilson H. Taylor Scholar Research areas: Federal budget policy, Health care policy and financing, ACA

 

Scott Gottlieb Resident Fellow Research areas: Trends in medicine, FDA policies, Medical technology development, CMS policies

 

Sally Satel Resident Scholar Research areas: Political trends in Medicine, Mental health/Transplant/ Domestic drug policy

 

Ramesh Ponnuru Visiting Fellow Research areas: Conservatives and health care policy

 

Tomas J. Philipson Visiting Scholar Research areas: Economics of pharmaceuticals, Health care trends

James C. Capretta Visiting Fellow Research areas: Market-based alternatives to the ACA

 

Thomas P. Miller Resident Scholar Research areas: Market-based alternatives to the ACA, Health insurance regulation

 

Roger Bate Visiting Scholar Research areas: international environmental and health agreements, Counterfeit pharmaceuticals

 

Thomas Peter Stossel Visiting Scholar Research areas: Medical innovation, Health care and health care policy

 

Joel M. Zinberg Visiting Scholar Research areas: Health policy, Health care reform, Practice of medicine, ACA

Headlines and Highlights

Mammograms are a mixed bag
Joel M. Zinberg, US News & World Report
Breast cancer screening early and often, no matter how well-intentioned, is costly and counterproductive. Finding every last cancer, no matter how small or innocuous, does not save lives and subjects many women to unnecessary treatment.

Absent strong action, Medicare goes the way of Greece
Joseph Antos, Real Clear Markets
Unless we take strong action, Medicare might go the way of Greece.

Medicare at 50
James C. Capretta, National Review Online
Medicare as it stands is unsustainable. How can we fix it for future generations?

Kicking the habit
Sally Satel, The Wall Street Journal
If addiction is a brain disease, addicts are mad, sick and defective. If it’s a failure of will, users are bad, immoral and weak.

The California child vaccination mandates and the everlasting cycle of infectious diseases
Tomas J. Philipson, Forbes
Understanding the economic incentives driving infectious diseases and governing the impact of policies that aim to control them is of immense importance to global health.

Pharmaceuticals and pharmaphobes
Thomas Peter Stossel, Drug Topics
If FDA’s thorough review indicates that a treatment safely promises potential benefits, the agency can approve its use before decisive evidence exists. Grandstanding by “pharmaphobes” should not jeopardize this sensible compromise.

Nuns are Obamacare’s latest victim
Ramesh Ponnuru, Bloomberg View
A group of Catholic nuns, the Little Sisters of the Poor, wants relief from the Affordable Care Act’s mandate that it offer contraceptive coverage to its employees. The nuns lost a court case this week — and everyone who cares about religious freedom should be troubled by the reasons why.

Latest media appearances from our health scholars

from AEI » Latest Content http://ift.tt/1w4Wum2